Key result
Pediatric lipid screening with genetic testing identifies causative FH mutations in ~61% with elevated LDL-C.
Cross-Sectional (n=15,665)
Yes
Answers are grounded in this paper and cite their sources.
AIM: Familial hypercholesterolemia (FH) is an underdiagnosed autosomal dominant genetic disorder characterized by high levels of plasma low-density lipoprotein cholesterol (LDL-C) from birth. This study aimed to assess the genetic identification of FH in children with high LDL-C levels who are identified in a universal pediatric FH screening in Kagawa, Japan. METHOD: In 2018 and 2019, 15,665 children aged 9 or 10 years underwent the universal lipid screening as part of the annual health checkups for the prevention of lifestyle-related diseases in the Kagawa prefecture. After excluding secondary hyper-LDL cholesterolemia at the local medical institutions, 67 children with LDL-C levels of ≥ 140 mg/dL underwent genetic testing to detect FH causative mutations at four designated hospitals. RESULTS: The LDL-C levels of 140 and 180 mg/dL in 15,665 children corresponded to the 96.3 and 99.7 percentile values, respectively. Among 67 children who underwent genetic testing, 41 had FH causative mutations (36 in the LDL-receptor, 4 in proprotein convertase subtilisin/kexin type 9, and 1 in apolipoprotein B). The area under the curve of receiver operating characteristic curve predicting the presence of FH causative mutation by LDL-C level was 0.705, and FH causative mutations were found in all children with LDL-C levels of ≥ 250 mg/dL. CONCLUSION: FH causative mutations were confirmed in almost 60% of the referred children, who were identified through the combination of the lipid universal screening as a part of the health checkup system and the exclusion of secondary hyper-LDL cholesterolemia at the local medical institutions.
No takes yet. Share an insight, caveat, or question.
Matsunaga et al. (2021) conducted a cross-sectional in Familial hypercholesterolemia (n=15,665). Universal pediatric lipid screening followed by genetic testing for LDL-C ≥140 mg/dL was evaluated on Presence of familial hypercholesterolemia causative genetic mutations among referred children with LDL-C ≥140 mg/dL (AUC 0.705). Universal pediatric lipid screening plus genetic testing identified FH causative mutations in 41 of 67 children with LDL-C ≥/dL.
Synapse has enriched 10 related papers. Consider them for comparative context: